Triple
T9807245
| Position | Surface form | Disambiguated ID | Type / Status |
|---|---|---|---|
| Subject | Pharmaceuticals Division |
E238182
|
entity |
| Predicate | strategicPriorityOf |
P35432
|
FINISHED |
| Object | Roche Group |
E46707
|
NE FINISHED |
How this triple was built (3 steps)
Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.
NER
Named-entity recognition
gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Roche Group | Statement: [Pharmaceuticals Division, strategicPriorityOf, Roche Group]
NED1
Entity disambiguation (via context triple)
gpt-5-mini-2025-08-07
Target entity: Roche Group Context triple: [Pharmaceuticals Division, strategicPriorityOf, Roche Group]
-
A.
Roche
Roche is a common surname of French origin borne by various notable individuals across fields such as architecture, politics, and the arts.
-
B.
Roche
chosen
Roche is a major Swiss multinational healthcare company and one of the world’s leading pharmaceutical and diagnostics firms.
-
C.
Novartis
Novartis is a global Swiss-based pharmaceutical company known for developing innovative medicines across a wide range of therapeutic areas.
-
D.
Sanofi
Sanofi is a major French multinational pharmaceutical company known for developing prescription medicines, vaccines, and consumer healthcare products worldwide.
-
E.
Schering
Schering is a German surname most notably associated with Ernst Schering, a 19th-century pharmacist and founder of the pharmaceutical company Schering AG.
- F. None of above.
- G. Unsure - the case is ambiguous/there is not enough information to decide.
PD
Predicate disambiguation
gpt-5-mini-2025-08-07
Target predicate: strategicPriorityOf Context triple: [Pharmaceuticals Division, strategicPriorityOf, Roche Group]
-
A.
planningPriority
Indicates the relative importance or urgency assigned to an item, task, or objective when organizing or scheduling plans.
-
B.
typeOfPriority
Indicates the specific priority level or category assigned to something relative to other items or tasks.
-
C.
managementPriority
chosen
Indicates the relative level of importance or urgency assigned to managing or addressing a particular entity, issue, or task.
-
D.
missionPriority
Indicates the relative level of importance or urgency assigned to a mission compared to other missions or tasks.
-
E.
identifiesAsPriorityUses
Indicates that one entity designates or treats another entity as a priority for use or utilization.
- F. None of above.
Provenance (4 batches)
The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.
| Step | Stage | Batch ID | Status | When |
|---|---|---|---|---|
| creating | Elicitation | batch_69ca84defac48190abc1148804f184c1 |
completed | March 30, 2026, 2:12 p.m. |
| NER | Named-entity recognition | batch_69cdab7ddaac8190a5584a5c863fbaa3 |
completed | April 1, 2026, 11:34 p.m. |
| NED1 | Entity disambiguation (via context triple) | batch_69d79445b9288190a684184285966fa8 |
completed | April 9, 2026, 11:57 a.m. |
| PD | Predicate disambiguation | batch_69cd03dd2da881909052fbf29736a773 |
completed | April 1, 2026, 11:39 a.m. |
Created at: March 30, 2026, 8:29 p.m.